ADVFN ADVFN

Hot Features

Icon for default Inscrivez-vous gratuitement pour obtenir des cotations en temps réel, des graphiques interactifs, un flux d'options en direct et plus encore.
China Pharma Holdings Inc

China Pharma Holdings Inc (CPHI)

0,716
-0,106
(-12,90%)
Fermé 07 Juin 10:00PM
0,716
0,00
(0,00%)
Après les heures de négociation: 10:56PM

China Pharma Holdings Inc (CPHI) Action

Votre Hub pour des idées et discussions en direct en temps réel

Premium

Statistiques et détails clés

Dernier
0,716
( -12,90% )
Prix Achat
-
Prix Vente
-
Volume échangé
76 876
0,7101 Fourchette du Jour 0,83
0,3818 Plage de 52 semaines 2,05
Cap du marché
Clôture Veille
0,822
Ouverture
0,8087
Dernière Transaction
100
@
0.716
Dernière heure de transaction
Volume financier
US$ 57 928
VWAP
0,753531
Volume moyen (3 m)
US$ 260 757
Actions en circulation
40 522 002
Rendement du Dividende (LTM)
Ratio Cours sur Bénéfices
-2,9
Bénéfice par action (BPA)
-0,35
Chiffre d'affairess (LTM)
3,99M
Bénéfice net (LTM)
-3,55M

À propos de China Pharma Holdings Inc

China Pharma Holdings, Inc. develops, manufactures, and markets pharmaceutical products for human use in the People’s Republic of China. The company provides products in the form of dry powder injectables, liquid injectables, tablets, capsules, and cephalosporin oral solutions. Its products include ... China Pharma Holdings, Inc. develops, manufactures, and markets pharmaceutical products for human use in the People’s Republic of China. The company provides products in the form of dry powder injectables, liquid injectables, tablets, capsules, and cephalosporin oral solutions. Its products include Cerebroprotein Hydroloysate injection to treat memory decline and attention deficit; Gastrodin injection for tiredness, loss of concentration, poor sleep, and traumatic syndromes of the brain; Propylgallate injection to treat cerebral thrombosis, coronary heart disease, and after surgery complications; Ozagrel Sodium to treat acute thrombotic cerebral infarction and dyskinesia; Alginic Sodium Diester injection for ischemic heart, cerebrovascular, and high lipoprotein blood diseases; Bumetanide injection for edema diseases, hypertension, acute renal failure, hyperkalemia, hypercalcemia, and acute drug poisoning; and Candesartan for hypertension. It offers Roxithromycin dispersible tablets for pharyngitis and tonsillitis; Cefaclor dispersible tablets for tympanitis, lower respiratory tract infection, urinary tract infections, and skin/skin tissue infection; Cefalexin capsules for acute tonsillitis; Andrographolide for sore throat caused by upper respiratory tract infection; Clarithromycin granules and capsules; and Naproxen Sodium and Pseudophedrine Hydrochlorida sustained release tablets, as well as Hepatocyte growth-promoting factors, Tiopronin, Compound Ammonium Glycyrrhetate S, and Omeparzole for the treatment of digestive diseases. In addition, the company provides Vitamin B6 injection; Granisetron Hydrochloride injection for nausea and vomiting caused by radiotherapy and chemotherapy during the treatment of malignant tumors; Noni Enzyme, a food supplement; sanitizers; and masks. It supplies its products to hospitals and OTC pharmacies through provincial and municipal pharmaceutical logistics companies. The company is based in Haikou, the People’s Republic of China. Show more

Secteur
Healthcare
Industrie
Pharmaceuticals
Siège social
Haikou, China
Fondé
-
China Pharma Holdings Inc est coté dans le secteur Healthcare de la American Stock Exchange avec le ticker CPHI. Le dernier cours de clôture d'China Pharma était de US$0,82. Au cours de la dernière année, les actions de China Pharma ont été négociées dans une fourchette de prix de US$ 0,3818 à US$ 2,05.

China Pharma compte actuellement 40 522 002 actions en circulation. La capitalisation boursière d'China Pharma est de US$29,01 million. China Pharma a un ratio cours/bénéfice (ratio PE) de -2.90.

CPHI Dernières nouvelles

PériodeVariationVariation %Ouver.HautBasMoyenne Vol. Quot.VWAP
1-0.0568-7.349896480330.77280.9010.716384540.82600699CS
40.146125.63607650460.56991.460.38188539060.90627784CS
120.079912.56091809460.63611.460.38182982400.88814707CS
26-0.914-56.07361963191.631.880.38181685900.92777001CS
52-0.974-57.63313609471.692.050.38181156841.14813932CS
1560.32683.58974358970.392.59770.0677509230.23371474CS
260-0.014-1.917808219180.732.59770.0637613600.27484395CS

CPHI - Frequently Asked Questions (FAQ)

What is the current China Pharma Holdings Inc share price?
The current share price of China Pharma Holdings Inc is US$ 0,716
How many China Pharma Holdings Inc shares are in issue?
China Pharma Holdings Inc has 40 522 002 shares in issue
What is the market cap of China Pharma Holdings Inc?
The market capitalisation of China Pharma Holdings Inc is USD 29,01M
What is the 1 year trading range for China Pharma Holdings Inc share price?
China Pharma Holdings Inc has traded in the range of US$ 0,3818 to US$ 2,05 during the past year
What is the PE ratio of China Pharma Holdings Inc?
The price to earnings ratio of China Pharma Holdings Inc is -2,9
What is the cash to sales ratio of China Pharma Holdings Inc?
The cash to sales ratio of China Pharma Holdings Inc is 10,56
What is the registered address of China Pharma Holdings Inc?
The registered address for China Pharma Holdings Inc is No. 17, Jinpan Road, Haikou, Hainan Province, 570216
What is the China Pharma Holdings Inc website address?
The website address for China Pharma Holdings Inc is www.chinapharmaholdings.com
Which industry sector does China Pharma Holdings Inc operate in?
China Pharma Holdings Inc operates in the Pharmaceuticals sector

CPHI Transactions

Plus

Transactions différées

Pour obtenir des transactions en temps réel, améliorez votre compte

Passer à la version en temps réel
Aucune Discussion Trouvée
Ajouter une Discussion

Dernières Valeurs Consultées

Delayed Upgrade Clock